Skip to main content
Article thumbnail
Location of Repository

Discovery and identification of potential biomarkers of pediatric Acute Lymphoblastic Leukemia

By Linan Shi, Jun Zhang, Peng Wu, Kai Feng, Jing Li, Zhensheng Xie, Peng Xue, Tanxi Cai, Ziyou Cui, Xiulan Chen, Junjie Hou, Jianzhong Zhang and Fuquan Yang
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2662805
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2001). AE: Chemokines and angiogenesis. Current Opinion in Rheumatology
    2. (2003). AE: Chemokines and chemokine receptors in rheumatoid arthritis. Seminars in Immunology
    3. (2005). Ascitic complement system in ovarian cancer.
    4. (2005). Buffler PA: Proteomic analysis of childhood leukemia. Leukemia
    5. (2005). Chatterjee N: Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics. Proc Natl Acad Sci USA
    6. (1995). Childhood Leukemias. New England
    7. (2006). Chow LP: Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCVrelated hepatocellular carcinoma using a proteomics approach. Proteomics
    8. (2005). Christopherson Richard I, Scott Mike A: Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individuals. Blood
    9. (2000). Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors.
    10. (2005). Cubizolles M: Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology
    11. (2002). EC: Use of proteomic patterns in serum to identify ovarian cancer. Lancet
    12. (2006). Estey E: Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia. Cancer
    13. (2003). Farias-Eisner R: Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis. Proc Natl Acad Sci USA
    14. (2002). Feng Z: Serum Protein Fingerprinting Coupled with a Pattern-matching Algorithm Distinguishes Prostate Cancer from Benign Prostate Hyperplasia and Healthy Men. Cancer Res
    15. (1997). Hanash SM: Quantitative analysis of Op 18 phosphorylation in childhood acute leukemia. Leukemia
    16. (2002). JG: Boosted Decision Tree Analysis of Surface-enhanced Laser Desorption/Ionization Mass Spectral Serum Profiles Discriminates Prostate Cancer from Noncancer Patients. Clinical Chemistry
    17. (2001). JG: Development of a Novel Proteomic Approach for the Detection of Transitional Cell Carcinoma of the Bladder in Urine.
    18. (1995). Kantarjian HM: Acute lymphoblastic leukemia. Cancer
    19. (2004). Lambris JD: C3a and C3b Activation Products of the Third Component of Complement (C3) Are Critical for Normal Liver Recovery after Toxic Injury 1. The Journal of Immunology
    20. (2001). Lambris JD: Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunological Reviews
    21. (2004). MP: Chemokines: Angiogenesis and metastases in lung cancer. Novartis Found Symp
    22. (2006). PJ: Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis.
    23. (2001). Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transfus Med
    24. (2002). Preneoplastic, and Malignant Prostate Cells Have Distinct Protein Expression Profiles Resolved by Surface Enhanced Laser Desorption/ Ionization Mass Spectrometry. Clinical Cancer Research
    25. (2003). Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform. Biochemical and Biophysical Research Communications
    26. (2004). Relling MV, Downing JR: Acute lymphoblastic leukaemia.
    27. (2003). RG: Putative protein markers in the sera of men with prostatic neoplasms.
    28. (2002). Serum Proteomic Patterns for Detection of Prostate Cancer.
    29. (2003). Tockman MS: Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer
    30. (1993). WM: Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.